What Disqualifies You From TMS

Coverage rules are usually written around a depression diagnosis, so plans tend to approve TMS most readily when major depression is the documented condition. Some plans and devices are cleared for other uses, but the safest read is that your covered indication depends on the diagnosis in your chart and your specific plan's policy — worth confirming with the clinic before assuming either way.

That is exactly the kind of individual medical question the clinical safety screen exists to answer, and it is not something a general article can decide for you. Your treating clinician reviews your full history and explains how any specific part of it affects candidacy. If this is your worry, the most direct path is to raise it at the consultation rather than self-screening from a checklist online.

Not usually. A denial is a coverage decision, and coverage decisions carry appeal rights — an internal appeal first, then an independent external review 4Ref 4U.S. Centers for Medicare & Medicaid Services / HealthCare.gov (2025).How to Appeal an Insurance Company Decision.appeal-denied-claiminternal-appealexternal-reviewcoverage-denial. Many denials come down to missing documentation of your diagnosis or prior medication trials, which your prescriber can often supply. Asking which specific criterion the plan cited tells you what the appeal needs to address.

For most plans, yes — coverage is generally built around depression that has not responded to standard treatment, and the economic evidence plans rely on describes TMS as cost-effective after about two antidepressant trials that did not work 1Ref 1Zemplényi A et al. (2022).Repetitive transcranial magnetic stimulation may be a cost-effective alternative to antidepressant therapy after two treatment failures in patients with major depressive disorder.tms-cost-effectivenesstms-coveragetreatment-resistant-depression-cost. If your chart does not yet reflect that history, the issue is documentation rather than a permanent disqualification.